Pharmafile Logo

dual tasking

- PMLiVE

BioNTech announces £1bn UK investment to boost regional R&D presence

The UK government has also agreed to award the company a grant of up to £129m

- PMLiVE

Researchers uncover promising treatment approach for inherited breast cancer

The study evaluated chemotherapy followed by a targeted cancer drug in patients before surgery

- PMLiVE

Clinical trials – overcoming the barriers to improved enrolment and retention

The struggle to make clinical trials easier to conduct and more attractive to patients while understanding the impact of human behaviour and everyday pressures

- PMLiVE

Medscape Oncology at ASCO 2025: Driving Innovation, Education & Better Patient Outcomes

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next...

Medscape Education

Map Treatment Pathways Virtually – Engaging Your Advisors Creatively

Optimize product strategy! Discover how virtual profiling can accurately map treatment pathways and pinpoint opportunities for your innovations while engaging your advisors in a creative way!

Impetus Digital

regeneron headquarters

Regeneron to acquire human genetics company 23andMe for $256m

The agreement comes two months after 23andMe filed for bankruptcy protection

- PMLiVE

AstraZeneca shares late-stage results for Airsupra in mild asthma patients

More than ten million asthma exacerbations occur in the US every year

- PMLiVE

Medscape Celebrates Eight Groundbreaking Publications at ATS 2025 International Conference

Medscape Education is proud to announce the presentation of eight innovative educational research publications at the American Thoracic Society (ATS) 2025 International Conference, held May 16–21 in San Francisco, CA....

Medscape Education

- PMLiVE

Pfizer gains rights to 3SBio’s investigational bispecific antibody in deal worth over $6bn

The candidate is in clinical development for colorectal cancer, lung cancer and gynaecological tumours

- PMLiVE

Merck’s Welireg granted FDA approval to treat rare tumour types PPGL

Up to 2,000 new cases of pheochromocytoma or paraganglioma are diagnosed in the US every year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links